Hormone therapy: a revolution in understanding prostate cancer

The Lancet Oncology

Volumn 9, Issue 11, 2008, Pages 1112-

  Arya, Manit ^a,b   Shergill, Iqbal S ^a   Grange, Philippe ^b   Emberton, Mark ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIANDROGEN; CYPROTERONE ACETATE; DIETHYLSTILBESTROL; ESTRADIOL BENZOATE; ESTROGEN DERIVATIVE; FLUTAMIDE; GONADORELIN; GONADORELIN AGONIST; TESTOSTERONE PROPIONATE;

ADVANCED CANCER; ANDROGEN BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CARDIOVASCULAR DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; MEDICAL CARE; MEDICAL RESEARCH; METASTASIS POTENTIAL; MULTIMODALITY CANCER THERAPY; NOTE; ORCHIECTOMY; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CANADA; HISTORY, 20TH CENTURY; HUMANS; MALE; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 54349122273     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70282-1     Document Type: Note

References (3)

1. The Nobel Prize in physiology or medicine 1966. http://nobelprize.org/nobel_prizes/medicine/laureates/1966/press.html (accessed Sept 22, 2008).
2. Huggins C., and Hodges C.V. Studies on prostate cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1 (1941) 293-297
3. The Veterans Administration Co-operative Urological Research Group. Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124 (1967) 1011-1017